Inventia Healthcare Limited
Indian Pharmaceutical Exporter ยท Diabetes & Endocrine Specialist ยท $36.5M Total Trade ยท DGFT Verified
Inventia Healthcare Limited is an Indian pharmaceutical exporter with a total trade value of $36.5M across 11 products in 6 therapeutic categories. Based on 1,098 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Metformin ($16.4M), Telmisartan ($5.3M), Dapagliflozin ($4.6M).
Inventia Healthcare Limited โ Export Portfolio & Destination Treemap

Who is Inventia Healthcare Limited? โ Company Overview & Market Position
Inventia Healthcare Limited, established on September 27, 1985, is a privately held pharmaceutical development and manufacturing company headquartered in Mumbai, Maharashtra, India. The company's Corporate Identification Number (CIN) is U24239MH1985PLC037597. As of August 7, 2025, Inventia Healthcare reported an annual revenue of $89.42 million USD, with a net profit of $6.04 million USD for the fiscal year ending March 31, 2024. The company employs approximately 962 individuals, reflecting its substantial presence in the pharmaceutical sector. In August 2024, Platinum Equity acquired a controlling stake in Inventia Healthcare, indicating a strategic move to enhance the company's growth and market reach.